<학력>

· 1990년 3월 - 1996년 2월: 계명대학교 의과대학 의학과

· 2000년 3월 - 2002년 2월: 계명대학교 대학원 의학석사

· 2002년 3월 - 2004년 2월: 계명대학교 대학원 의학박사

<경력>

· 2003년 3월 - 2005년 2월: 계명대학교 동산의료원 내분비내과 전임의

· 2005년 3월 - 2005년 8월: 계명대학교 의과대학 내분비내과 임상전임강사

· 2005년 9월 - 2008년 2월: 계명대학교 의과대학 내분비내과 전임강사

· 2008년 3월 - 2011년 2월: 계명대학교 의과대학 내분비내과 조교수

· 2010년 8월 - 2011년 8월: UC San Diego, Divison of Endocrinology & Metabolism 연수

· 2011년 7월 - 2013년 9월: 경북대학교 의학전문대학원 내분비내과 조교수 

· 2013년 10월 - 2018년 9월: 경북대학교 의학전문대학원 내분비내과 부교수

· 2017년 4월 - 2023년 12월: 경북대학교병원 내분비대사내과 분과장

· 2018년 10월 - 현재: 경북대학교 의과대학 내분비내과 교수

· 2020년 9월 - 2021년 8월 : 경북대학교병원 생명의학연구원 원장

<학회활동>

대한내과학회 정회원

대한당뇨병학회 정회원

대한내분비학회 정회원

대한생화학분자생물학회 정회원

대한분자세포생물학회 정회원

전) 대구경북내과학회 공보이사

현) 대한내과학회 무임소이사

현) 대한당뇨병학회 무임소이사

현) 대한당뇨병학회 평의원

현) 대한내분비학회 평의원

현) 한국지질동맥경회학회 평의원

현) 대구경북당뇨병내분비대사학회 회장

<수상경력>

· 2003년: 대한당뇨병학회 제16차 춘계학술대회 우수연제상

· 2004년: 계명대학교 대학원 올해의 우수논문상

· 2004년: 대한내과학회 우수논문상

· 2005년: 대한내분비학회 학연산 심포지엄 및 추계심포지엄 우수연제상

· 2006년: 대한내분비학회 Young investigator award

· 2007년: 한일당뇨병심포지움 Young investigator award

· 2010년: 대한당뇨병학회 Young investigator award 

· 2023년: 대한내분비학회 EnM Academic Award 

<논문>

1. Jeon HJ, Byun JK, Lee SB, Son KH, Lim JY, Lee DS, Kim KS, Park JW, Shin GR, Kim YJ, Jin J, Kim D, Kim DH, Yu JH, Choi YK*, Park KG*, Jeon YH*. N-methyl-D-aspartate receptors induce M1 polarization of macrophages: Feasibility of targeted imaging in inflammatory response in vivo. Cell and Bioscience. Accepted (*corresponding author)

2. Jin J, Byun JK, Choi YK*, Park KG*. Targeting glutamine metabolism as a therapeutic strategy for cancer. Experimental and Molecular Medicine. Accepted. Invited review. (*corresponding author)

3. Jin J, Woo H, Jang Y, Lee WK, Kim JG, Lee IK, Park KG*, Choi YK*. Novel Asian-specific visceral adiposity indices are associated with chronic kidney disease in Korean adults. Diabetes and Metabolism Journal. 2022. PMID: 36872065 (*corresponding author)

4. Kim DH, Kim MJ, Kim NY, Lee S, Byun JK, Yun JW, Lee J, Jin J, Chin J, Cho SJ, Lee IK, Choi YK, Park KG*. DN200434, an Orally Available Inverse Agonist of Estrogen-Related Receptor ?, Induces Ferroptosis in Sorafenib-Resistant Hepatocellular Carcinoma. BMB Reports. 2022. Nov;55(11):547-552. PMID: 36016501 (*corresponding author)

5. Jin J, Woo H, Jang Y, Lee WK, Kim JG, Lee IK, Park KG*, Choi YK*. Novel Asian-specific visceral adiposity indices are associated with chronic kidney disease in Korean adults. Diabetes and Metabolism Journal. 2022. (*corresponding author)

6. Kumar S, Jin J, Park HY, Kim MJ, Chin J, Lee S, Kim JG, Choi YK*, Park KG*. DN200434 inhibits vascular smooth muscle cell proliferation and prevents neointima formation in mice after carotid ligation. Endocrinology and Metabolism. 2022 Oct;37(5):800-809. PMID: 36168774 (*corresponding author)

7. Lee S, Byun JK, Kim NY, Jin J, Woo H, Choi YK*, Park KG*. Melatonin inhibits glycolysis in hepatocellular carcinoma cells by downregulating mitochondrial respiration and mTORC1 activity. BMB Reports. 2022. Sep;55(9):459-464. PMID 35651333 (*corresponding author)

8. Kim HS, Yu JM, Jang HC, Choi EK, Park JH, Shon HS, Chung CH, Park KG, Cho JH, Kim W, Lee KH, Lee JH, Yoo SJ. Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea. Diabetes Metabolic Syndrome and Obesity. 2022 May 11;15:1495-1503. PMID: 35591905

9. Byun JK, Lee S, Kang GW, Lee YR, Park SY, Song IS, Yun JW, Lee J, Choi YK*, Park KG*. Macropinoycotis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma. Journal of Experimental and Clinical Cancer Research. 2022 Mar 14;41(1):98. PMID: 35287706. (*corresponding author)

10. Kim YJ, Lee S, Jin J, Woo H, Choi YK*, Park KG*. Cassiaside C inhibits M1 polarization of macrophages by downregulating glycolysis. International Journal of Molecular Science. 2022 Feb 1;23(3):1696. PMID: 35163619. (*corresponding author)

11. Jin J, Lee SW, Lee WK, Jeon JH, Kim JG, Lee IK, Choi YK*, Park KG*. Year-long trend in HbA1c levels in patients with type 2 diabetes during the COVID-19 pandemic. Endocrinology and Metabolism. 2021 Oct;36(5):1142-1146. PMID: 34674507. (*corresponding author)

12. Park SD, Kim NY, Jeon JH, Kim JG, Lee IK, Park KG, Choi YK. Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes. The Korean Journal of Internal Medicine. 2021 Jul;36(4):942-948. PMID: 34092049.

13. Park HY, Kim MJ, Lee S, Jin J, Lee S, Kim JG, Choi YK*, Park KG*. Inhibitory effect of a glutamine antagonist on proliferation and migration of VSMCs via simultaneous attenuation of glycolysis and oxidative phosphorylation. International Journal of Molecular Science. 2021 May 25;22(11):5602. PMID: 34070527. (*corresponding author)

14. Park HY, Kim MJ, Kim YJ, Lee S, Jin J, Lee S, Choi YK*, Park KG*. V-9302 inhibits proliferation and migration of VSMCs, and reduces neointima formation in mice after carotid artery ligation. Biochemical and Biophysical Research Communications. 2021 May 6;560:45-51. PMID: 33965788 (*corresponding author)

15. Jo JR, Lee SE, An S, Nedumaran B, Ghosh S, Park KG, Kim YD. Gluconeogenic signals regulate hepcidin gene expression via a CRBN-KLF15 axis. BMB Reports. 2021 Apr;54(4):221-226. PMID: 33795032 

16. Park SD, Kim SW, Moon JS, Lee YY, Cho NH, Lee JH, Jeon JH, Choi YK, Kim MK, Park KG*. Impact of social distancing due to COVID-19 on the changes in HbA1c level in people with type 2 diabetes. Diabetes and Metabolism Journal. 2021 Jan;45(1):109-114. PMID: 33264833 (*corresponding author)

17. Byun JK, Park M, Lee S, Yun JW, Lee J, Kim JS, Cho SJ, Jeon HJ, Lee IK, Choi YK*, Park KG*. Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity. Molecular Cell. 2020 Nov 19;80(4):592-606. PMID: 33159855 (*corresponding author)

18. Kim J, Hwang H, Yoon H, Lee JE, Oh JM, An H, Ji HD, Lee S, Cha E, Ma MJ, Kim DS, Lee SJ, Kadayat TM, Song J, Lee SW, Jeon JH, Park KG, Lee IK, Jeon YH, Chin J, Cho SJ. An orally available inverse agonist of estrogen-related receptor ? showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer. European Journal of Medicinal Chemistry. 2020 Jul 14;205:112501. doi: 10.1016/j.ejmech.2020.112501. Online ahead of print. PMID: 32758860

19. Kim MK, Jeon JH, Kim SW, Moon JS, Cho NH, Han E, You JH, Lee JY, Hyun M, Park JS, Kwon YS, Choi YK, Kwon KT, Lee SY, Jeon EJ, Kim JW, Hong HL, Kwon HH, Jung CY, Lee YY, Ha E, Chung SM, Hur J, Ahn JH, Kim NY, Kim SW, Chang HH, Lee YH, Lee J, Park KG, Kim HA, Lee JH. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea. Diabetes and Metabolism Journal. 2020 Aug;44(4):602-613. PMID:32794386. 

20. Lee S, Byun JK, Park M, Kim SW, Lee S, Kim JG, Lee IK, Choi YK*, Park KG*. Melatonin inhibits vascular smooth muscle cell proliferation and apoptosis through upregulation of Sestrin2. Experimental and Therapeutic Medicine. 2020 Jun;19(6):3454-3460. PMID: 32373191 (*corresponding author)

21. Lee BW, Lee YH, Park CY, Rhee EJ, Lee WY, Kim NH, Choi KM, Park KG, Choi YK, Cha BS, Lee DH; Korean Diabetes Association (KDA) Fatty Liver Research Group. Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. Diabetes and Metabolism Journal. 2020 Jun;44(3):382-401. PMID: 32431115. Review

22. Seo HY, Lee SH, Lee JH, Kang YN, Hwang JS, Park KG, Kim MK, Jang BK. Src inhibition attenuates liver fibrosis by preventing hepatic stellate cell activation and decreasing connective tissue growth factor. Cells. 2020 Feb 27;9(3). pii: E558. PMID: 32120837

23. Kim MJ, Kim N, Jung YA, Lee SH, Jung GS, Kim JG, Lee IK, Lee S, Choi YK*, Park KG*. Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates renal fibrosis by unilateral ureteral obstruction in mice. Diabetes and Metabolism Journal. 2020 Feb;44(1):186-192. PMID: 31701692 (*corresponding author)

24. Seo HY, Lee SH, Lee JH, Kang YN, Choi YK, Hwang JS, Park KG, Jang BK, Kim MK. Clusterin attenuates hepatic fibrosis by inhibiting hepatic stellate cell activation and downregulating the Smad3 signaling pathway. Cells. 2019 Nov 14;8(11). pii: E1442. doi: 10.3390/cells8111442. PMID: 31739636

25. Byun JK, Park M, Yun JW, Lee J, Kim JS, Cho SJ, Lee YM, Lee IK, Choi YK*, Park KG*. Oncogenic KRAS signaling activates mTORC1 through COUP-TFII-mediated lactate production. EMBO Reports. 2019. Jun;20(6). pii: e47451. PMID: 30988000 (*corresponding author)

26. Seo JB, Choi YK, Woo HI, Jung YA, Lee S, Lee S, Park M, Lee IK, Jung GS, Park KG*. Gemigliptin attenuates renal fibrosis through down-regulation of the NLRP3 inflammasome. Diabetes and Metabolism Journal. 2019 Dec;43(6):830-839. PMID: 30877711 (*corresponding author)

27. Kim SW, Jeon JH, Moon JS, Jeon EJ, Kim MK, Lee IK, Park KG*. Low normal free thyroxine levels in euthyroid men are associated with prediabetes. Diabetes and Metabolism Journal. 2019 Oct;43(5):718-726. PMID: 30968614. Accepted (*corresponding author)

28. Min BK, Park S, Kang HJ, Kim DW, Ham HJ, Ha CM, Choi BJ, Lee JY, Oh CJ, Yoo EK, Kim HE, Kim BG, Jeon JH, Hyeon DY, Hwang D, Kim YH, Hee CH, Lee T, Kim J, Choi YK, Park KG, Chowla A, Lee J, Harris RA, Lee IK. Pyruvate dehydrogenase kinase is a metabolic checkpoint for polarization of macrophages to the M1 phenotype. Frontiers in Immunology. 2019 May 7;10:944. doi: 10.3389/fimmu.2019.00944. eCollection 2019.PMID: 31134063

29. Karunakaran U, Elumalai S, Moon JS, Jeon JH, Jeon JH, Kim ND, Park KG, Won KC, Leem J, Lee IK. Myricetin Protects Against High Glucose-Induced β-Cell Apoptosis by Attenuating Endoplasmic Reticulum Stress via Inactivation of Cyclin-Dependent Kinase 5. Diabetes and Metabolism Journal. 2019 Apr;43(2):192-205. PMID: 30688049  

30. Thoudam T, Ha CM, Leem J, Chanda D, Park JS, Kim HJ, Jeon JH, Choi YK, Liangpunsakul S, Huh YH, Kwon TH, Park KG, Harris RA, Park KS, Rhee HW, Lee IK. PDK4 Augments ER-Mitochondria Contact to Dampen Skeletal Muscle Insulin Signaling During Obesity. Diabetes. 2019 Mar;68(3):571-586. PMID: 30523025  

31. Kim J, Song J, Ji HD, Yoo EK, Lee JE, Lee SB, Oh JM, Lee S, Hwang JS, Yoon H, Kim DS, Lee SJ, Jeong M, Lee S, Kim KH, Choi HS, Lee SW, Park KG, Lee IK, Kim SH, Hwang H, Jeon YH, Chin J, Cho SJ. Discovery of Potent, Selective, and Orally Bioavailable Estrogen-related Receptor ? Inverse Agonists to Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer. Journal of Medicinal Chemistry. 2019 Feb 28;62(4):1837-1858. PMID: 30657313 

32. Kadayat TM, Lee G, Jung K, Hwang HJ, Joo J, Hahan D, Hwang H, Park KG, Cho SJ, Kim KH, Chin J. Synthesis of unique dimethyl thiazoline intermediate of novel PPAR? agonists. Tetrahedron Letters. 2018. Dec;59(50):4384-4386

33. Jeong S, Byun JK, Cho SJ, Chin J, Lee IK, Choi YK, Park KG*. Transcription factor Eb is required for macropinocytosis-mediated growth recovery of nutrient-deprived KRAS-mutant cells. Nutrients. 2018 Nov 2;10(11). pii: E1638. PMID: 30400219. (*corresponding author)

34. Kim SW, Park KG*. Response: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome. Diabetes and Metabolism Journal. 2018 Aug;42(4):350-352. PMID: 30136454 (*corresponding author) 

35. Park BY, Jeon JH, Go Y, Ham HJ, Kim JE, Yoo EK, Kwon WH, Jeoung NH, Jeon YH, Koo SH, Kim BG, He L, Park KG, Harris RA, Lee IK. PDK4 deficiency suppresses hepatic glucagon signaling by decreasing cyclic AMP levels. Diabetes. 2018 Oct;67(10):2054-2068. PMID: 30065033

36. Seo HY, Kim MK, Lee SH, Hwang JS, Park KG, Jang BK. Kahweol ameliorates the liver inflammation through the inhibition of NF-?B and STAT3 activation in primary Kupffer cells and primary hepatocytes. Nutrients. 2018 Jul 4;10(7). PMID: 29973533

37. Jeong JY, Jeon JH, Bae KH, Choi YK, Park KG, Kim JG, Won KC, Cha BS, Ahn CW, Kim DW, Lee CH, Lee IK. Smart Care Based on Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-center Randomized Controlled Trial. Telemedicine Journal and E-Health. 2018 Aug;24(8):604-613. PMID: 29341843

38. Bae KH, Kim SW, Choi YK, Seo JB, Kim NG, Kim CY, Lee WK, Lee S, Kim JG, Lee IK, Lee JH, Park KG*. Serum levels of PCSK9 are associated with coronary angiographic severity in patients with acute coronary syndrome. Diabetes and Metabolism Journal. 2018 Jun;42(3):207-214. PMID: 29885102 (*corresponding author)

39. Choi YK, Park KG*. Targeting glutamine metabolism for cancer treatment. Biomolecules and Therapeutics. 2018 Jan 1;26(1):19-28. PMID: 29212303. Invited Review (*corresponding author) 

40. Seo HY, Jung YA, Lee SH, Hwang JS, Park KG, Kim MK, Jang BK. Kahweol decreases hepatic fibrosis by inhibiting the expression of connective tissue growth factor via the transforming growth factor-beta signaling pathway. Oncotarget. 2017 Aug 1;8(50):87086-87094. 

41. Kim JH, Bae KH, Byun JK, Lee S, Kim JG, Lee IK, Jung GS, Lee YM, Park KG*. Lactate dehydrogenase-A is indispensable for vascular smooth muscle cell proliferation and migration. Biochemical and Biophysical Research Communications. 2017 Oct 7;492(1):41-47. PMID: 28818664 (*corresponding author)

42. Byun JK, Choi YK, Kim JH, Jeong JY, Jeon HJ, Kim MK, Hwang I, Lee SY, Lee YM, Lee IK*, Park KG*. A positive feedback loop between Sestrin2 and mTORC2 is required for the survival of glutamine-depleted lung cancer cells. Cell Reports. 2017 Jul 18;20(3):586-599. PMID: 28723563 (*co-corresponding author)

43. Kim MJ, Choi YK, Park SY, Jang SY, Lee JY, Ham HJ, Kim BG, Jeon HJ, Kim JH, Kim JG, Lee IK*, Park KG*. PPAR? reprograms glutamine metabolism in sorafenib-resistant HCC. Molecular Cancer Research. 2017 Sept;15(9):1230-1242. PMID; 28584024 (*co-corresponding author)

44. Oh CJ, Ha CM, Park S, Choe MS, Huh YH, Kim HJ, Kweon HS, Lee J, Lee SJ, Jeon JH, Harris R, Park KG*, Lee IK*. Pyruvate dehydrogenase 4 deficiency attenuates cisplatin-induced acute kidney injury. Kidney International. 2017 Apr;91(4):880-895. PMID: 28040265 (*co-corresponding author) 

45. Choi SH, Leem J, Park S, Lee CK, Park KG, Lee IK. Gemigliptin ameliorates western-diet-induced metabolic syndrome in mice. Canadian Journal of Physiology and Pharmacology. 2017 Feb;95(2):129-139. PMID: 27918207

46. Seo HY, Jeon JH, Jung YA, Jung GS, Lee EJ, Choi YK, Park KG, Choe MS, Jang BK, Kim MK, Lee IK. Fyn deficiency attenuates renal fibrosis by inhibition of phosphor-STAT3. Kidney International. 2016. Dec;90(6):1285-1297. PMID 27616741

47. Go Y, Jeong JY, Jeong NH, Jeon JH, Park BY, Kang HJ, Ha CM, Choi YK, Lee SJ, Ham HJ, Kim BG, Park KG, Park SY, Lee CH, Choi CS, Park TS, Lee WN, Harris RA, Lee IK. Inhibition of pyruvate dehydrogenase 2 protects against hepatic steatosis through modulation of TCA cycle anaplerosis and ketogenesis. Diabetes. 2016 Oct;65(10):2876-87. PMID: 27385159

48. Lee GH, Oh KJ, Kim HR, Han HS, Lee HY, Park KG, Nam KH, Koo SH, Chae HJ. Effect of BI-1 on insulin resistance through regulation of CYPE1. Scientific Reports. 2016 Aug 31;6:32229. PMID: 27576594

49. Jung GS, Jeon JH, Choi YK, Jang SY, Park SY, Kim SW, Byun JK, Kim MK, Lee S, Shin EC, Lee IK, Kang YN*, Park KG*. Pyruvate dehydrogenase kinase regulates hepatitis C virus replication. Scientific Reports. 2016 Jul 29;6:30846. PMID: 27471054 (*co-corresponding author)

50. Jang SY, Park SY, Lee HW, Choi YK, Park KG, Yoon GS, Tak WY, Kweon YO, Hur K, Lee WK. The combination of periostin overexpression and microvascular invasion is related to a poor prognosis for hepatocellular carcinoma. Gut and Liver. 2016 Nov 15;10(6):948-954. PMID: 27458178

51. Kim SW, Jeon JH, Lee WK, Lee S, Kim JG, Lee IK, Park KG.* Long-term effects of oral contraceptives on the prevalence of diabetes in post-menopausal women: 2007-2012 KNHANES. Endocrine. 2016 Sep;53(3):816-22. PMID: 27160817 (*corresponding author)

52. Seo W, Eun HS, Kim SY, Yi HS, Lee YS, Park SH, Jang MJ, Jo EJ, Kim SC, Han YM, Park KG, Jeong WI. Exosome-Mediated Activation of Toll-Like Receptor 3 in Stellate Cells Stimulates Interleukin-17 Production by γδ T cells in Liver Fibrosis. Hepatology. 2016 Aug;64(2):616-31. PMID: 27178735 

53. Jung GS, Jeon JH, Choe MS, Kim SW, Lee IK, Kim MK*, Park KG*. Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice. Diabetes and Metabolism Journal. 2016 Jun;40(3):211-21. PMID: 27098503 (*Co-corresponding authors)

54. Kim SW, Bae KH, Seo JB, Jeon JH, Lee WK, Lee IK, Kim JG, Park KG*. Association between household size, residential area, and osteoporosis: Analysis of 2008?2011. The Korean Journal of Internal Medicine. 2016. Jul;31(4):712-21. PMID: 27079326 (*corresponding author)

55. Lee YM, Kim SA, Lee IK, Kim JG, Park KG, Jeong JY, Jeon JH, Shin JY, Lee DH. Effect of a Brown Rice based Vegan Diet and Conventional Diabetic Diet on Glycemic Control of Patients with Type 2 Diabetes: a 12-week Randomized Clinical Trial. PLoS One. 2016 Jun 2;11(6):e0155918. PMID: 27253526  

56. Kim JH, Choi YK, Byun JK, Kim MK, Kang YN, Kim SH, Lee S, Jang BK*, Park KG*. Estrogen-related receptor ? is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27. Experimental and Molecular Medicine. 2016 Mar 4;48:e213. PMID: 26940882 (*co-corresponding author).

57. Hwang IR, Choi YK, Lee WK, Kim JG, Lee IK, Kim SW*, Park KG*. Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2-10-2011. Osteoporosis International. 2016 Jan;27(1):257-265. PMID:26373982 (*co-corresponding author)

58. Lee SJ, Jeong JY, Oh CJ, Park S, Kim JY, Kim HJ, Doo Kim N, Choi YK, Do JY, Go Y, Ha CM, Choi JY, Huh S, Ho Jeoung N, Lee KU, Choi HS, Wang Y, Park KG, Harris RA, Lee IK. Pyruvate dehydrogenase 4 promotes vascular calcification via smad1/5/8 phosphorylation. Scientific Reports. 2015 Nov 12;5:16577. PMID:26560812

59. Lee YS, Yi HS, Suh YG, Byun JS, Eun HS, Kim SY, Seo W, Jeong JM, Choi WM, Kim MH, Kim JH, Park KG, Jeong WI. Blockade of retinol metabolism protects T cell-induced hepatitis by increasing migration of regulatory T cells. Molecules and Cells. 2015 Nov 30;38(11):998-1006. PMID: 26537191

60. Kim JH, Choi YK, Do JY, Choi YK, Ha CM, Lee SJ, Jeon JH, Lee WK, Choi HS, Park KG*, Lee IK*. Estrogen-related receptor ? plays a key role in vascular calcification through the upregulation of BMP2 expression. Arteriosclerosis Thrombosis Vascular Biology. 2015 Nov;35(11):2384-90. PMID: 26404484 (*co-corresponding author)

61. Choi SH, Park S, Oh CJ, Leem J, Park KG, Lee IK. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation. Vascular Pharmacology. 2015 Oct;73:11-9. PMID: 26187356

62. Jung GS, Jeon JH, Choi YK, Jang SH, Park SY, Kim MK, Shin EC, Jeong WL, Lee IK, Kang YN*, Park KG*. Small heterodimer partner attenuates profibrotic features of hepatitis C virus infected cells. Liver International. 2015. Oct;35(10):2233-45. PMID: 25976932 (*co-corresponding author)

63. Kim MJ, Park SK, Lee JH, Jung CY, Sung DJ, Park JH, Yoon YS, Park J, Park KG, Song DK, Cho H, Kim ST, Koo SH. Salt inducible kinase 1 terminates cAMP signaling by an evolutionarily conserved negative feedback loop in beta cells. Diabetes. 2015 September;64(9):3189-202. PMID: 25918234

64. Kim SW, Jeon JH, Choi YK, Lee WK, Hwang IR, Kim JG, Lee IK, Park KG*. Association of urinary sodium/creatinine ratio with bone mineral density in postmenopausal women: KNHANES 2008-2011. Endocrine. 2015 Aug;49(3):791-799. PMID: 25614039 (*corresponding author)

65. Karunakaran U, Park SJ, Jun DY, Sim T, Park KG, Kim MO, Lee IK. Non-receptor Tyrosine Kinase Inhibitors Enhances β-cell Survival by Suppressing the PKCδ Signal Transduction Pathway in Streptozotocin-Induced β-cell Apoptosis. Cellular Signaling. 2015 Jun;27(6): 1066-74. PMID: 25683919

66. Yi HS, Eun HS, Lee YS, Jung JY, Park SH, Park KG, Choi HS, Suh JM, Jeong WI. Treatment with 4-Methylpyrazole Modulated Stellate Cells and Natural Killer Cells and Ameliorated Liver Fibrosis in Mice. PLoS One. 2015 May 29;10(5):e0127946. PMID: 26024318

67. Byun JK, Choi YK, Kang YN, Jang BK, Kang KJ, Jeon YH, Lee HW, Jeon JH, Koo SH, Jeong WI, Harris R, Lee IK*, Park KG*. Retinoic acid-related orphan receptor alpha reprograms glucose metabolism in glutamine-deficient hepatoma cells. Hepatology. 2015 Mar;61(3):953-64. PMID: 25346526. (*co-corresponding author)

68. Kim JH, Bae KH, Choi YK, Go Y, Choe M, Jeon YH, Lee HW, Koo SH, Perfield II JW, Harris RA, Lee IK*, Park KG*. The FGF21 analogue, LY2405319, lowers blood glucose in streptozotocin-induced insulin-deficient mice by restoring brown adipose tissue function. Diabetes Obesity and Metabolism. 2015 Feb;17(2):161-9. PMID: 25359298 (*co-corresponding author)

69. Jha MK, Lee S, Park DH, Kook H, Park KG, Lee IK, Suk K. Diverse functional roles of lipocalin-2 in the central nervous system. Neuroscience and Biobehavioral Review. 2015 Feb;49C:135-56. PMID: 25511817 (review article)

70. Bae KH, Min AK, Kim JG, Lee IK*, Park KG*. Alpha lipoic acid induces hepatic fibroblast growth factor 21 expression via up-regulation of CREBH. Biochemical and Biophysical Research Communication. 2014 Dec 12;455(3-4):212-7. PMID: 25449271 (*co-corresponding author)

71. Park J, Yoon YS, Han HS, Kim YH, Ogawa Y, Park KG, Lee CH, Kim ST, Koo SH. SIK2 is critical in the regulation of lipid homeostasis and adipogenesis in vivo. Diabetes. 2014 Nov;63(11):3659-73. PMID: 24898145 

72. Ha CM, Park S, Choi YK, Jeong JY, Oh CJ, Bae KH, Lee SJ, Kim JH, Park KG, Jun DY, Lee IK. Activation of Nrf2 by dimethylfumarate improves vascular calcification. Vascular Pharmacology. 2014 Oct;63(1):29-36. PMID: 25135648

73. Yi HS, Lee YS, Byun JS, Seo W, Jeong JM, Park O, Duester G, Haseba T, Kim SC, Park KG, Gao Bin, WI Jeong. Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice. Hepatology. 2014 Sep;60(3):1044-53. PMID: 24668648 

74. Jung GS, Jeon JH, Jung YA, Choi YK, Kim HS, Kim JG, Park KG, Kim MK, Lee IK. Clusterin/Apolipoprotein J Attenuates Angiotensin II-Induced Renal Fibrosis. PLoS One. 2014 Aug 22;9(8):e105635. PMID: 25148511

75. Min AK, Bae KH, Jung YA, Choi YK, Kim MJ, Kim JH, Jeon JH, Kim JG, Lee IK*, Park KG*. Orphan nuclear receptor Nur77 mediates fasting-induced hepatic fibroblast growth factor 21 expression. Endocrinology. 2014 Aug;155(8):2924-31. PMID: 24885573 (*co-corresponding author)

76. Jung YA, Choi YK, Jung GS, Seo HY, Kim HS, Jang BK, Kim JG, Lee IK, Kim MK*, Park KG*. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis. Diabetes Research and Clinical Practice. 2014 Jul;105(1):47-57. PMID: 24842243. (*co-corresponding author)

77. Oh CJ, Park S, Kim JY, Kim HJ, Jeoung NH, Choi YK, Go Y, Park KG, Lee IK. Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms. Redox Biology. 2014 Jun 24;2: 855-64. PMID: 25009787

78. Seo HY, Jang BK, Jung YA, Kim HS, Jeon JH, Kim JG, Lee IK, Kim MK*, Park KG*. Phospholipase D1 decreases type I collagen levels in hepatic stellate cells via induction of autophagy. Biochemical and Biophysical Research Communication. 2014 Jun 20;449(1):38-43. PMID: 24802400 (*co-corresponding author)

79. Han HS, Jung CY, Yoon YS, Choi S, Choi D, Kang G, Park KG, Kim ST, Koo SH. Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism. Science Signaling. 2014 Feb 25;7(314). PMID: 24570487

80. Jung YA, Kim HK, Bae KH, Seo HY, Kim HS, Jang BK, Jung GS, Lee IK, Kim MK*, Park KG*. Cilostatzol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1. Experimental and Molecular Medicine. 2014 Jan 24;46:e73; doi:10.1038/emm.2013.413. PMID: 24458133 (*co-corresponding author)

81. Jeong YJ, Cho HJ, Magae J, Lee IK, Park KG*, Chang YC*. Ascofuranone suppresses EGF-induced HIF-1alpha protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells. Toxicology and Applied Pharmacology. 2013 Dec; 273(3):542-50. PMID: 24096035 (*co-corresponding author)

82. Lee YJ, Ha YJ, Kang YN, Kang KJ, Hwang JS, Chung WJ, Cho KB, Park KS, Kim ES, Seo HY, Kim MK, Park KG, Jang BK. The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma. PLoS One. 2013 Nov 25;8(11):e81540. PMID: 24282606

83. Kim JK, Kim JY, Kim HJ, Park KG, Harris RA, Cho WJ, Lee JT, Lee IK. Scoparone Exerts Anti-Tumor Activity against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity. PLoS One. 2013 Nov 15;8(11):e80391. PMID: 24260381

84. Choi YK, Park KG*. Metabolic roles of AMPK and Metformin in Cancer Cells. Molecules and Cells. 2013 Oct; 36(4):279-287. PMID: 23794020 (*corresponding author) Invited review

85. Seo HY, Kim MK, Jung YA, Jang BK, Park KG*, Lee IK*. Clusterin decreases hepatic SREBP-1c expression and lipid accumulation. Endocrinology. 2013 May; 154(5):1722-30. PMID: 23515283 (*co-corresponding author)

86. Karunakaran U, Park KG*. A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense. Diabetes and Metabolism Journal. 2013 Apr;37(2):106-12. Invited review. PMID: 23641350 (*Corresponding author)

87. Kang HJ, Seo HA, Go Y, Oh CH, Jeong NH, Park KG*, Lee IK*. Dimethylfumarate suppresses adipogenic differentiation in 3T3-L1 preadipocytes through inhibition of STAT3 activity. PLoS One. 2013 Apr; 8(4) e61411. PMID: 23637829 (*co-corresponding author)

88. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK*, Park KG*. Serum irisin levels in new-onset type 2 diabetes. Diabetes Research and Clinical Practice. 2013 Apr;100(1):96-101. PMID: 23369227 (*co-corresponding author)

89. Min AK, Jeong JY, Go Y, Choi YK, Kim YD, Lee IK*, Park KG*. cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis. Diabetologia. 2013 Feb;56(2):412-22. PMID: 23150180 (*co-corresponding author)

90. Oh CJ, Kim JY, Choi YK, Kim HJ, Jeong JY, Bae KH, Park KG, Lee IK. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta/Smad signaling. PLoS One. 2012 Oct 8;7(10):e45870. PMID: 23056222

91. Seo HA, Kim SW, Jeon EJ, Jeong JY, Moon SS, Lee WK, Kim JG, Lee IK, Park KG*. Association of the DDAH2 gene polymorphism with type 2 diabetes and hypertension. Diabetes Research and Clinical Practice. 2012 Oct 14;98(1):125-31. PMID: 22579530 (*corresponding author)

92. Lee KM, Seo YJ, Kim MK, Seo HA, Jeong JY, Choi HS, Lee IK*, Park KG*. Mediation of glucolipotoxicity in INS-1 rat insulinoma cells by small heterodimer partner interacting leucine zipper protein. Biochemical and Biophysical Research Communication. 2012 Mar 23;419 (4):768-773. PMID: 22387546 (*co-corresponding author)

93. Kim MK, Kim HS, Lee IK, Park KG*. Endoplasmic Reticulum Stress and Insulin Biosynthesis. Experimental Diabetes Research. 2012;2012:509437.  PMID: 22474424 (*corresponding author) Invited review

94. Oh CJ, Kim JY, Min AK, Harris RA, Park KG, Kim HJ, Lee IK. Sulforaphane Attenuates Hepatic Fibrosis via NF-E2-related factor 2-Mediated Inhibition of Transforming Growth Factor-β/Smad Signaling. Free Radical Biology and Medicine. 2012 Feb 1; 52(3):671-82. PMID: 22155056

95. Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG*, Lee IK* Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. Life Sciences. 2012 Jan 30;90(5-6):200-5. PMID: 22154902 (*co-corresponding author)

96. Jung GS, Kim MK, Jung YA, Kim HS, Park IS, Min BH, Lee KU, Kim JG, Park KG*, Lee IK*. Clusterin/Apolipoprotein J Attenuates the Development of Renal Fibrosis. Journal of The American Society of Nephrology. 2012 Jan;23(1):73-85. PMID: 22052058 (*co-corresponding author)

97. Koh EH, Lee WJ, Lee SA, Kim EH, Cho EH, Jeong E, Kim DW, Kim MS, Park JY, Park KG, Lee HJ, Lee IK, Lim S, Jang HC, Lee KH, Lee KU. Effects of alpha-lipoic acid on body weight in obese subjects. American Journal of Medicine. 2011 Jan;124(1):85.e1-8. PMID: 21187189

98. Kim HJ, Kim JY, Lee SJ, Kim HJ, Oh CJ, Choi YK, Lee HJ, Do JY, Kim SY, Kwon TK, Choi HS, Lee MO, Park IS, Park KG, Lee KU, Lee IK. α-Lipoic acid prevents neointimal hyperplasia via induction of p38 mitogen-activated protein kinase/Nur77-mediated apoptosis of vascular smooth muscle cells and accelerates postinjury reendothelialization. Arteriosclerosis Thrombosis Vascular Biology. 2010 Nov;30(11):2164-72. PMID: 20829507 

99. Lee MW, Chanda D, Yang J, Oh H, Kim SS, Yoon YS, Hong S, Park KG, Lee IK Choi CS, Hanson RW, Choi HS, Koo SH. Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. Cell Metabolism. 2010 Apr;11(4): 331-9. PMID: 20374965

100. Kim MK, Chanda D, Lee IK, Choi HS*, Park KG*. Targeting orphan nuclear receptor SHP in metabolic diseases. Expert Opinion on Therapeutic Targets. 2010 Apr;14(4): 453-66. PMID: 20230197 (*co-corresponding author) Invited review

101. Min AK, Kim MK, Seo HY, Kim HS, Jang BK, Hwang JS, Choi HS, Lee KU, Park KG*, Lee IK*. Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-β signaling pathway. Biochemical and Biophysical Research Communication. 2010 Mar;393(3): 536-41. PMID: 20153726 (*co-corresponding author)

102. Seo HY, Kim MK, Min AK, Kim HS, Ryu SY, Kim NK, Lee KM, Kim HJ, Choi HS, Lee KU, Park KG*, Lee IK*. Endoplasmic Reticulum Stress-Induced Activation of Activating Transcription Factor 6 Decreases cAMP-stimulated Hepatic Gluconeogenesis via Inhibition of CREB. Endocrinology. 2010 Feb;151(2): 561-8. PMID: 20022930  (*co-corresponding authors)

103. Lee KM, Seo HY, Kim MK, Min AK, Ryu SY, Kim YN, Park YJ, Choi HS, Lee KU, Park KG*, Lee IK*. Orphan nuclear receptor small heterodimer partner inhibits angiotensin II-stimulated PAI-1 expression in vascular smooth muscle cells. Experimental and Molecular Medicine. 2010 Jan;42(1): 21-9. PMID: 19887897 (*co-corresponding authors)

104. Lee KM, Lee HJ, Kim MK, Kim HS, Jung GS, Hur SH, Kim HT, Cho WH, Kim JG, Kim BW, Lim JO, Choi HS, Lee KU, Park KG*, Lee IK*. Cilostazol Inhibits High Glucose- and Angiotensin II-induced Type 1 Plasminogen Activator Inhibitor Expression in Artery Wall and Neointimal Region after Vascular Injury. Atherosclerosis. 2009 Dec;207(2): 391-8. PMID: 19586629 (*co-corresponding author)

105. Jung GS, Kim MK, Choe MS, Lee KM, Kim HS, Park YJ, Choi HS, Lee KU, Park KG*, Lee IK*. The Orphan Nuclear Receptor Small Heterodimer Partner Attenuates Renal Fibrosis. Journal of The American Society of Nephrology. 2009 Oct;20(10): 2154-61. PMID: 19643931 (*co-corresponding author)

106. Kim HJ, Yoo EK, Kim JY, Choi YK, Kim JK, Lee HJ, Jeong NH, Lee KU, Park IS, Min BH, Park KG, Aronow BJ, Sata M, Lee IK. Protective Role of Clusterin/Apolipoprotein J against Neointimal Hyperplasia via Antiproliferative Effect on Vascular Smooth Muscle Cells and Cytoprotective Effect on Endothelial Cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009 Oct;29(10):1558-64. PMID: 19696405

107. Jung YA, Lee KM, Kim MK, Jung GS, Seo YJ, Kim HS, Cho HC, Lee KU, Park KG*, Lee IK*. Forkhead Transcription Factor FoxO1 Inhibits Insulin- and Transforming Growth Factor-β-stimulated Plasminogen Activator Inhibitor-1 Expression. Biochemical and Biophysical Research Communication. 2009 Sep;386(4):757-61. PMID: 19563779 (*co-corresponding author)

108. Kim SY, Jeong NH, Oh CJ, Choi YK, Lee HJ, Kim HJ, Kim JY, Hwang JH, Tadi S, Yim YH, Lee KU, Park KG, Huh S, Min KN, Jeong KH, Park MG, Kwak TH, Kweon GR, Inukai K, Shong M, and Lee IK. Activation of NAD(P)H:quinone oxidoreductase 1 (NQO1) prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation. Circulation Research. 2009 Apr;104(7):842-50. PMID: 19229058

109. Park KG*, Min AK*, Koh EH*, Kim HS, Kim MO, Park HS, Kim YD, Yoon TS, Jang BK, Hwang JS, Kim JB, Choi HS, Park JY, Lee IK, Lee KU. Alpha-lipoic acid decreases hepatic lipogenesis through AMPK-dependent and ?independent pathways. Hepatology. 2008 Nov;48(5): 1477-86. PMID: 18972440 (*co-first authors)

110. Seo HY, Kim YD, Lee KM, Min AK, Kim MK, Kim HS, Won KC, Park JY, Lee KU, Choi HS, Park KG*, Lee IK*. ER stress-induced Activation of ATF6 Decreases Insulin Gene Expression via Upregulation of Orphan Nuclear Receptor SHP. Endocrinology. 2008 Aug;149(8):3832-41. PMID: 18450959 (*co-corresponding author)

111. Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, Jang WG, Cho WJ, Ha J, Lee IK, Lee CH, Choi HS. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase dependent regulation of the orphan nuclear receptor SHP. Diabetes. 2008 Feb;57(2): 306-14. PMID: 17909097

112. Kim HS, Park KG, Koo TB, Huh S, Lee IK. The modulating effects of the overexpression of uncoupling protein 2 on the formation of reactive oxygen species in vascular cells. Diabetes Research and Clinical Practice. 2007 Sep;77(Suppl 1):S46-8 

113. Choe SS, Choi AH, Lee JW, Kim KH, Chung JJ, Park J, Lee KM, Park KG, Lee IK, Kim JB. Chronic Activation of Liver X Receptor Induces beta-cell Apoptosis through Hyperactivation of Lipogenesis. Diabetes. 2007 Jul;56(6): 1534-43. PMID: 17369526

114. Kim HJ*, Park KG*, Yoo EK, Kim YH, Kim YN, Kim HS, Kim HT, Park JY, Lee KU, Jang WG, Kim JG, Kim BW, Lee IK. Effects of PGC-1α on TNF-α-induced MCP-1 and VCAM-1 expression and NF-κB activation in human aortic smooth muscle and endothelial cells. Antioxidants and Redox Signaling. 2007 Mar;9(3):301-7. PMID: 17184171 (*co-first author)

115. Park KG*, Lee KM*, Seo HY, Suh JH, Kim HS, Wang L, Won KC, Lee HW, Park JY, Lee KU, Kim JG, Kim BW, Choi HS, Lee IK. Glucotoxicity in the INS-1 rat insulinoma cell line is mediated by the orphan nuclear receptor SHP. Diabetes. 2007 Feb;56(2):431-7. PMID: 17259388 (*co-first authors)

116. Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK, Park JY, Lee KU, Kim JG, Lee IK. Alpha-Lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappaB transcriptional activity. Experimental and Molecular Medicine. 2007 Feb;39(1):106-13. PMID: 17334234 

117. Jang WG, Kim EJ, Park KG, Park YB, Choi HS, Kim HJ, Kim YD, Kim KS, Lee KU, Lee IK. Glucocorticoid receptor mediated repression of human insulin gene expression is regulated by peroxisome proliferator-activated receptor-? coactivator ?. Biochemical and Biophysical Research Communication. 2007 Jan;352(3):716-21. PMID: 17150186

118. Park KG*, Lee KM*, Chang YC, Magae J, Ando K, Kim KB, Kim YN, Kim HS, Park JY, Lee KU, Lee IK. The Ascochlorin derivative, AS-6, inhibits TNF-alpha-induced adhesion molecule and chemokine expression in rat vascular smooth muscle cells. Life Sciences. 2006 Dec;80(2):120-6. PMID: 16989870 (*co-first authors)

119. Lee KM*, Park KG*, Kim YD, Kim HT, Cho WH, Lee HJ, Kim HS, Han SW, Koh GY, Park JY, Lee KU, Lee IK. Alpha-Lipoic Acid Inhibits Fractalkine Expression and Prevents Neointimal Hyperplasia after Balloon Injury in Rat Carotid Artery. Atherosclerosis. 2006 Nov;189(1):106-14. PMID: 16413026 (*co-first authors)

120. Kim YD*, Park KG*, Morishita R, Kaneda Y, Kim SY, Song DK, Kim HS, Nam CW, Lee HC, Lee KU, Park JY, Kim BW, Kim JG, Lee IK. Liver-directed gene therapy of diabetic rats using an HVJ-E vector containing EBV plasmids expressing insulin and GLUT 2 transporter. Gene Therapy. 2006 Feb;13(3):216-24. PMID: 16177820 (*co-first author)

121. Park JY, Park KG, Kim HJ, Kang HG, Ahn JD, Kim HS, Kim YM, Son SM, Kim IJ, Kim YK, Kim CD, Lee KU, Lee IK. The effects of overexpressing recombinant uncoupling protein-2 on proliferation, migration and PAI-1 expression in human vascular smooth muscle cells. Diabetologia. 2005 May;48(5):1022-28. PMID: 15827742

122. Kim MJ*, Park KG*, Lee KM, Kim HS, Kim SY, Kim CS, Lee SL, Chang YC, Park JY, Lee KU, Lee IK. Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F. Hypertension. 2005 Arp;45(4):552-6. PMID: 15723965 (*co-first author)

123. Park KG, Ryu SY, Lee IK. Circular dumbbell AP-1 and E2F decoy oligodeoxynucleotide based antiproliferative gene therapy. Gene Therapy and Molecular Biology. 2005 Feb; 9:15-22. Review article 

124. Jang WG, Kim HS, Park KG, Park YB, Yoon KH, Han SW, Hur SH, Park KS, Lee IK. Analysis of proteome and transcriptome of tumor necrosis factor stimulated vascular smooth muscle cells with or without alpha lipoic acid. Proteomics. 2004 November;4(11):3383-93. PMID: 15378733

125. Park KG, Kim MJ, Kim HS, Lee SJ, Song DK, Lee IK. Prevention and treatment of macroangiopathy: focusing on oxidative stress. Diabetes Research and Clinical Practice. 2004 Dec;66(Suppl):S57-S62. PMID: 15563982. Review article

126. Ahn SY, Cho CH, Park KG, Lee HJ, Lee S, Park SK, Lee IK, Koh GY. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. American Journal of Pathology. 2004 May;164(5):1663-72. PMID: 15111313

127. Ahn JD, Morishita R, Kaneda Y, Kim HJ, Kim YD, Lee HJ, Lee KU, Park JY, Kim YH, Park KK, Chang YC, Yoon KH, Kwon HS, Park KG, Lee IK. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo. Gene Therapy. 2004 Jun;11(11):916-23. PMID: 14961072

128. Park KG, Park KS, Kim MJ, Kim HS, Suh YS, Ahn JD, Park KK, Chang YC, Lee IK. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Research & Clinical Practice.  2004 Feb;63(2):135-42. PMID: 14739054

129. Ahn JD, Kim CH, Magae J, Kim YH, Kim HJ, Park KK, Hong S, Park KG, Lee IK, Chang YC. E2F decoy oligodeoxynucleotides effectively inhibit growth of human tumor cells. Biochemical and Biophysical Research Communication. 2003 Oct;310(4):1048-53. PMID: 14559221